A clinical endpoint is a predefined outcome or event measured in a clinical study to determine whether a treatment or device has a clinically meaningful effect on patients. In clinical development translation, endpoints appear in protocols, statistical analysis plans, case report forms, clinical study reports, and informed consent documents, where they must be translated consistently to avoid ambiguity in data collection, safety reporting, and submission summaries.
Translators encounter endpoints when localizing clinical protocols, informed consent forms, statistical analysis plans, clinical study reports, and regulatory briefing packages. Endpoint names often combine statistical and medical language, so the translation must preserve the exact definition across all study documents to keep site staff, ethics committees, data reviewers, and regulators aligned.
A common error is translating the same endpoint with different wording in the protocol and the clinical study report, which makes the data look inconsistent during regulatory review. Another error is changing 'composite endpoint' into a single outcome, or mixing 'primary' and 'key secondary' when translating tables, which can distort the study's main conclusions.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →